九州大学 研究者情報
研究者情報 (研究者の方へ)入力に際してお困りですか?
基本情報 研究活動 教育活動 社会活動 病院臨床活動
島添 隆雄(しまぞえ たかお) データ更新日:2019.05.27

准教授 /  薬学研究院 臨床薬学部門 医療薬科学専攻


主な研究テーマ
抗がん剤の副作用としての末梢神経障害に関する研究
キーワード:抗がん剤、末梢神経障害
2017.01~2025.04.
一般社団法人福岡市薬剤師会との共同事業「節薬バッグ運動」の推進
キーワード:節薬バッグ、残薬、アドヒアランス
2012.06~2027.05.
生活習慣病(糖尿病・がん)の予防・進行抑制における食生活・漢方薬・健康補助食品の重要性についての研究
キーワード:がん、糖尿病、食生活、漢方薬、健康補助食品
2005.02.
サーカディアンリズムに関する研究
キーワード:視交叉上核、サーカディアンリズム
1995.04.
研究業績
主要著書
1. 島添 隆雄, 小野寺憲治, 市川勤, 岡野善郎, 小野信文, 小野寺敏, 神田循吉, 重山昌人, 篠塚達雄, 清水俊一, 谷口良彦, 土肥弘久, 徳山尚吾, 新倉雄一, 原明義, 平野俊彦, 松田佳和, 松村人志, 森山峰博, イラストでみる 疾病の成り立ちと薬物療法, 医学評論社, P. 305 - P. 322, 2013.09, 疾病ごとの検査方法、診断、薬物治療について著した教科書的書籍.
主要原著論文
1. Naohiro Iwata, MOSABURO KAINUMA, Kobayashi D, toshio kubota, Naoko Sugawara, Aiko Uchida, Sahoko Ozono, Yuki Yamamuro, Norihiro Furusyo, Koso Ueda, Eiichi Tahara, Takao Shimazoe, The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark, Front Pharmacol, 10.3389/fphar.2016.00174, 7, 214, 2016.05, Cinnamon bark is commonly used in traditional Japanese herbal medicines (Kampo medicines). The coumarin contained in cinnamon is known to be hepatotoxic, and a tolerable daily intake (TDI) of 0.1 mg/kg/day, has been quantified and used in Europe to insure safety. Risk assessments for hepatotoxicity by the cinnamon contained in foods have been reported. However, no such assessment of cinnamon bark has been reported and the coumarin content of Kampo medicines derived from cinnamon bark is not yet known. To assess the risk for hepatotoxicity by Kampo medicines, we evaluated the daily coumarin intake of patients who were prescribed Kampo medicines and investigated the relation between hepatotoxicity and the coumarin intake. The clinical data of 129 outpatients (18 male and 111 female, median age 58 years) who had been prescribed keishibukuryogankayokuinin (TJ-125) between April 2008 and March 2013 was retrospectively investigated. Concurrent Kampo medicines and liver function were also surveyed. In addition to TJ-125, the patients took some of the other 32 Kampo preparations and 22 decoctions that include cinnamon bark. The coumarin content of these Kampo medicines was determined by high performance liquid chromatography (HPLC). TJ-125 had the highest daily content of coumarin (5.63 mg/day), calculated from the daily cinnamon bark dosage reported in the information leaflet inserted in each package of Kampo medicine. The coumarin content in 1g cinnamon bark decoction was 3.0 mg. The daily coumarin intake of the patients was 0.113 (0.049-0.541) mg/kg/day, with 98 patients (76.0%) exceeding the TDI. Twenty-three patients had an abnormal change in liver function test value, but no significant difference was found in the incidence of abnormal change between the group consuming less than the TDI value (6/31, 19.4%) and the group consuming equal to or greater than the TDI value (17/98, 17.3%). In addition, no abnormal change related to cinnamon bark was found for individual patients. This paper was done to assess the risk of hepatotoxicity by the coumarin contained in Kampo medicines and to clarify whether or not the Kampo preparations in general use that contain cinnamon bark may be safely used in clinical practice..
2. Kaori Koyanagi, toshio kubota, Kobayashi D, Taro Kihara, Takeo Yoshida, Takamasa Miisho, Takao Shimazoe, Yoshiko Sakamoto, Jyunichi Takaki, Takashi Seo, Tomoko Miura, Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs, Front Pharmacol, 10.3389/fphar.2016.00212. eCollection 2016., 20, 212, 2016.07, Abstract
BACKGROUND:
Medication adherence has an important influence on health outcomes in patients with chronic diseases. However, few studies have been performed in Japan to determine factors related to medication non-adherence.
OBJECTIVE:
The aim of this study was to identify prescription factors related to medication non-adherence by investigating patient characteristics, all prescriptions, and prescriptions for oral antidiabetic drugs (OADs).
METHODS:
A retrospective cross-sectional survey of prescription data about implementation of dosing regimen was performed at community pharmacies engaged in appropriate use of leftover drugs. We evaluated the amount of drugs originally prescribed and the reduced amount after use of leftover drugs, and then calculated prescription reduction ratio (PRR). We analyzed prescription factors contributing to non-adherence based on the PRR.
RESULTS:
Prescription information for 1207 patients was reviewed, revealing that patients were non-adherent to 58% of prescriptions. Lack of a drug copayment, fewer concurrent drugs, and drugs not in single-dose packaging were associated with non-adherence. Among the 1207 patients, 234 prescriptions for diabetes and 452 OAD formulations were included. Forty-seven percent of prescriptions and 29% of the formulations were non-adherent. A higher dosing frequency and preprandial administration were associated with non-adherence. Among the OADs, adherence was lower for α-glucosidase inhibitors and biguanides than for sulfonylureas.
CONCLUSIONS:
Several factors related to patient characteristics, general drug prescriptions, and OAD prescriptions were associated with non-adherence. Further consideration will be needed to improve adherence to medication in Japan. Health care providers should perform more careful monitoring of adherence in patients with the factors identified by this study..
3. Kaori Koyanagi, toshio kubota, Kobayashi D, Taro Kihara, Takeo Yoshida, Takamasa Miisyo, Tomoko Miura, Yoshiko Sakamoto, Jyunichi Takaki, Takashi Seo, Takao Shimazoe, Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs., Frontiers in Pharmacology, 10.3389/fphar.2016.00212, 2016.07, Medication adherence has an important influence on health outcomes in patients with chronic diseases. However, few studies have been performed in Japan to determine factors related to medication non-adherence.
OBJECTIVE:
The aim of this study was to identify prescription factors related to medication non-adherence by investigating patient characteristics, all prescriptions, and prescriptions for oral antidiabetic drugs (OADs).
METHODS:
A retrospective cross-sectional survey of prescription data about implementation of dosing regimen was performed at community pharmacies engaged in appropriate use of leftover drugs. We evaluated the amount of drugs originally prescribed and the reduced amount after use of leftover drugs, and then calculated prescription reduction ratio (PRR). We analyzed prescription factors contributing to non-adherence based on the PRR.
RESULTS:
Prescription information for 1207 patients was reviewed, revealing that patients were non-adherent to 58% of prescriptions. Lack of a drug copayment, fewer concurrent drugs, and drugs not in single-dose packaging were associated with non-adherence. Among the 1207 patients, 234 prescriptions for diabetes and 452 OAD formulations were included. Forty-seven percent of prescriptions and 29% of the formulations were non-adherent. A higher dosing frequency and preprandial administration were associated with non-adherence. Among the OADs, adherence was lower for α-glucosidase inhibitors and biguanides than for sulfonylureas.
CONCLUSIONS:
Several factors related to patient characteristics, general drug prescriptions, and OAD prescriptions were associated with non-adherence. Further consideration will be needed to improve adherence to medication in Japan. Health care providers should perform more careful monitoring of adherence in patients with the factors identified by this study..
4. Takao Shimazoe, Sachiko Nakamura, Kenji Kobayashi, Shigenori Watanabe, Kyoko Miyasaka, Akira Kono, Akihiro Funakoshi, Role of 5-HT1B receptors in entrainment disorder of Otsuka Long Evans Tokushima Fatty (OLETF) rats, Neuroscience, 10.1016/j.neuroscience.2003.08.024, 123, 1, 201-205, 123, 201-205, 2004.01.
5. Shimazoe T, Morita M, Ogiwara S, Kojiya T, Goto J, Kamakura M, Moriya T, Shinohara K, Takiguchi S, Kono A, Miyasaka K, Funakoshi A, Ikeda M., Cholecystokinin-A receptors regulate photic input pathways to the circadian clock., FASEB Journal, VOL. 22, 1479-1490, 2008.05.
6. 小柳香織, 窪田 敏夫, 小林 大介, 木原太郎, 吉田武夫, 三井所尊正, 斎藤友亮, 打越英惠, 高木淳一, 瀬尾隆, 島添 隆雄, 「節薬バッグ運動 外来患者の残薬の現状とその有効活用による医療費削減の取組み」, 薬学雑誌, 133, 11, 1215-1221, 2013.11, Pharmacists, being compensated through the new dispensing fee are required to educate patients on their adhesion to the use of the prescribed drugs and to inventory the levels of leftover drugs in outpatients. Recently, Fukuoka City Pharmaceutical Association started a campaign for regulating leftover drugs (Setsuyaku Bag Campaign). Thirty-one pharmacies joined the campaign. Pharmacists distributed convenience bags named ‘SETSUYAKU-BAG.’ The patients put the leftover drugs in the bags, and brought them to community pharmacies. The pharmacists inventoried them, and reported their results to the doctors. Then, the doctors adjusted the prescriptions. We counted and analyzed the old and new inventories. The number of leftover drugs was 252 for a total value was \839,655. Cost of leftover drug prescriptions could be reduced by \702,695, and the value of drugs thrown away was \94,801. In total, we could reduce the amount of leftover drugs by 83.7%. The cost of leftover drug for non- one dose package (ODP) is higher than that for ODP. However, there were no significant effects of age, sex, number and kinds of drugs, prescription days and premium contribution rate. These results suggest that prescription regulation by inventory of leftover drugs in community pharmacies could reduce medical expenses. Further studies are necessary in order to account for patents’ health and establish more efficient patient education to raise outpatients’ adherence to the new programs..
主要総説, 論評, 解説, 書評, 報告書等
主要学会発表等
1. Shimazoe T, Kubota T, Kobayashi D, Kawashiri T, Kihara T, Takaki J, Koyanagi K, Nakashiba T, Kawanami M, Tsuzuki K, Nagatomi S, Tanaka T, Assessment of non-adherence factors using original score sheets in SETSUYAKU-BAG Campaign of Japan, FIP, 2018.09.
2. 島添 隆雄、小林 大介、窪田 敏夫、川浪 望恵、 小栁香織、加崎哲夫、國武雅弘、竹下文明、安東恵津子、中芝高彦、永冨茂、郡司清志、金子絵里奈、林田諭、吉居瞳、三井所 尊正、高木 淳一、木原 太郎、瀬尾 隆、田中 泰三、 , 節薬バッグ運動の経緯とさらなる展開 ー残薬調整および医師への情報発信がもたらす効果ー, 第28回医療薬学会年会, 2018.11.
3. Takao Shimazoe, Setsuyaku Bag Campaign ~from regulation of leftover drugs to improvement of QOL~, Asian Conference on Clinical Pharmacy 2017, 2017.07, 福岡市薬剤師会、大分市薬剤師会との共同研究である節薬バッグ運動の経緯と成果につて発表した。.
4. Takao Shimazoe, Improvement of adherence and QOL in Setsuyaku Bag Campaign, The 16th Asian Conference on Clinical Pharmacy, 2016.07.
5. Takao Shimazoe, Advancement of the campaign on regulation of leftover drugs for outpatients called "Setsuyaku Bag Campaign" in Fukuoka of Japan, The 15th Asian Conference on Clinical Pharmacy, 2015.11, Our campaign named "Setsuyaku Bag Campaign2 developed more and more. From now, we will focus on the improvement of QOL in patients..
6. 島添 隆雄, Advancement of the campaign on regulation of leftover drugs for outpatients called "Setsuyaku Bag Campaign" in Fukuoka of Japan, The 15th Asian Conference on Clinical Pharmacy, 2015.06, 福岡市薬剤師会との共同事業「節薬バッグ運動」の展開についてPlenary lectureを行った。.
7. 島添 隆雄, Expansion of campaign on regulation of leftover drugs for outpatients, The 14th Asian Conference on Clinical Pharmacy, 2014.11, 福岡市薬剤師会との共同事業「節薬バッグ運動」を福岡市医療件に拡大し、データを解析した。その結果、1枚の処方せんあたり2割が削減できることが明らかになった。.
8. Takao Shimazoe, Study on Left Drugs of Patients to Raise Adherence in Community Pharmacy
, 2013.09, In Japan, increase of medical expenses produces many economical deficits. Therefore, the reduction is a critical issue for us. However, patients sometimes forget or stop taking medicines. Confirmation of leftover drugs by pharmacists is required to get patient education fee by revision of the law. Some reports suggest that more than 40 % of prescribed drugs are kept in patient’s home. When such leftover drugs are reconsidered, it will produce much economical merit. Therefore, if pharmacists regulate prescription by suggestion to doctors, significant reduction of medical deficits will be also possible. Fukuoka Pharmaceutical Association started the trial of campaign for reduction of leftover drugs (Setsuyaku Bag Campaign) to citizens with our department in Kyushu University for 3 months in this winter. This campaign is as follows. Pharmacists distributed convenient bags named Setsuyaku Bags to the patients. The patients put leftover drugs in, and brought them to the community pharmacies. The pharmacists checked them, and conducted prescription question to the doctors. Then, the doctors changed prescriptions. The pharmacists recorded the details in the cheksheets and sent them to us. We assessed them from various points of view. Thirty-one community pharmacies of Fukuoka city joined in this trial. Total number of patients was 252. Saved amount was 839,665 Japanese yen (1,000 US$). The amount estimates 300,000,000,000 Japanese yen when it spreads to all of Japan. These results suggest that control of prescription by pharmacists can contribute to saving of medical fees. Moreover, such a try will connect to mutual understanding within patients, doctors and pharmacists as team-based medicine. It will connect to proper prescription and proper use in near future. In this spring, this campaign was spread to all of Fukuoka city. I will also present the results in ACCP 2013..
9. Takao Shimazoe, New Epoch of Clinical Pharmacy Education from Students to Pharmacists in Japan, The 12th Asian Conference on Clinical Pharmacy, 2012.07, The skill of physical assessment will be indispensable for pharmacists both in hospital and community pharmacy.
Multidisciplinary care (team based care) will be more and more important in near future .
.
10. Takao Shimazoe, Commit our dream of multidisciplinary care to health care system students, 2010.07.
11. 岡田知子、小林大介、窪田敏夫、島添隆雄, コーヒー飲用による糖代謝および炎症マーカーの改善に関する臨床研究, 日本薬学会第129年会, 2009.03.
12. 島添隆雄、末宗洋、樋口駿, 薬剤師のリーダーとしての資質を有する薬剤師の育成, 日本薬学会第128年会, 2008.03.
13. Ikeda M, Morita M, Takiguchi S, Funakoshi A, Shimazoe T, Retinal signal processing for the circadian clock inputs via amacrine cell cholecystokinin~A receptors., Annual Meeting for Neuroscience 2007, 2007.11.
学会活動
所属学会名
日本薬学教育学会
和漢医薬学会
健康医療医学会
日本東洋医学会
日本薬剤師会
日本医療薬学会
Society for Neuroscience
日本神経科学学会
日本薬学会
日本癌学会
日本時間生物学会
日本神経精神薬理学会
日本薬理学会
学協会役員等への就任
2017.08~2019.07, 和漢医薬学会, 代議員.
2016.04~2018.03, 日本薬理学会, 財務委員.
2010.04~2019.05, 公益社団法人福岡県薬剤師会, 理事.
2014.04~2020.03, 健康医療医学会, 理事.
2010.04~2019.03, 実務実習支援センター, 副センター長.
2000.04~2019.06, 日本神経精神薬理学会, 評議員.
1995.10~2027.06, 中華医学会福田部会.
2000.04~2019.03, 日本時間生物学会, 評議員.
1998.04~2019.03, 日本薬理学会, 評議員.
学会大会・会議・シンポジウム等における役割
2018.03.26~2018.03.28, 日本薬学会第138年会, 審査員.
2017.03.14~2017.03.14, 第26回神経行動薬理若手研究者の集い, 世話人、座長.
2018.08.18~2018.08.20, 第29回霧島神経薬理フォーラム, 世話人、司会.
2017.08.26~2018.08.27, 第34回和漢医薬学会, 組織委員.
2018.08.19~2018.08.21, 第28回霧島神経薬理フォーラム, 司会(Moderator).
2018.07.01~2018.07.03, 第46回日本神経精神薬理学会, 座長(Chairmanship).
2016.07.02~2016.07.03, 第46回日本神経精神薬理学会, 座長(Chairmanship).
2015.08.16~2015.08.18, 第26回霧島神経薬理フォーラム, 座長(Chairmanship).
2015.03.26~2015.03.28, 日本薬学会第135年会, 座長(Chairmanship).
2015.03.17~2015.03.17, 第24回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2014.08.15~2014.08.17, 第25回霧島神経薬理フォーラム, 司会(Moderator).
2013.08.17~2013.08.18, 第24回霧島神経薬理フォーラム, 司会(Moderator).
2012.08.17~2012.08.19, 第23階霧島神経薬理フォーラム, 司会(Moderator).
2013.03.20~2013.03.20, 第22回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2011.08.19~2011.08.21, 第22回霧島神経薬理フォーラム, 司会(Moderator).
2010.08.20~2012.08.22, 第21回霧島神経薬理フォーラム, 司会(Moderator).
2009.08.21~2009.08.23, 第20回桐霧島神経薬理フォーラム, 司会(Moderator).
2012.03.18~2012.03.18, 第12回 社団法人福岡県薬剤師会 ファーマシューティカルケアシンポジウム, 座長(Chairmanship).
2012.03.13~2012.03.13, 第21回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2010.03.14~2010.05.14, 第19回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2009.03.19~2009.03.19, 第18回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2008.08.22~2008.08.24, 第19回霧島神経薬理フォーラム, 司会(Moderator).
2006.03, 第15回神経行動薬理若手研究者の集い, 座長(Chairmanship).
2003.03, 日本薬理学会, 座長(Chairmanship).
2017.03.05~2017.03.05, 第17回ファーマシューティカルケアシンポジウム, 企画・運営・シンポジスト.
2016.03.06~2016.03.06, 第16回ファーマシューティカルケアシンポジウム, 企画・運営・シンポジスト.
2016.09.17~2016.09.19, 第26回医療薬学会年会, シンポジスト.
2017.08.26~2017.08.27, 未来プロジェクト, 世話人.
2016.08.27~2016.08.28, 未来プロジェクト, 世話人.
2017.08.26~2017.08.27, 第34回和漢医薬学会学術大会, 実行委員.
2014.11.07~2014.11.07, JSC International Symposium, 実行委員.
2014.11.07~2014.11.09, 第21回日本時間生物学会, 実行委員.
2016.08.15~2016.08.17, Asian Conference on Clinical Pharmacy, Board member.
2017.08.26~2016.08.27, 第34回和漢医薬学会学術大会, 組織委員.
2015.03.08~2015.03.08, 第25回神経行動薬理若手研究者の集い, 世話人.
2014.08.15~2014.08.17, 第25回霧島神経薬理フォーラム, 世話人.
2015.03.17~2015.05.29, 第24回神経行動薬理若手研究者の集い, 世話人.
2014.03.18~2014.03.18, 第23回神経行動薬理若手研究者の集い, 世話人.
2010.08.20~2010.08.22, 第21回霧島神経薬理フォーラム, 世話人.
2013.08.17~2013.08.18, 第24回霧島神経薬理フォーラム, 主催.
2012.08.17~2012.08.19, 第23回霧島神経薬理フォーラム, 世話人.
2011.08.19~2011.08.21, 第22回霧島神経薬理フォーラム, 世話人.
2009.08.21~2009.08.23, 第20回霧島神経薬理フォーラム, 世話人.
2013.08.27~2013.08.28, The 未来プロジェクト2013, 世話人.
2013.03.20~2013.03.20, 第22回神経行動薬理若手研究者の集い, 実行委員.
2013.08.07~2013.08.07, 先導的薬剤師養成に向けた実践的アドバンスト教育プログラムの共同開発 【教育評価手法開発シンポジウム】 , 企画・運営.
2013.09.21~2013.09.22, 第23回日本医療薬学会年会, シンポジスト.
2013.03.21~2013.03.23, 第86回日本薬理学会年会, 会場責任者.
2012.08.25~2013.08.26, The未来プロジェクト2012, 世話人.
2011.08.27~2011.08.28, The 未来プロジェクト2011, 世話人.
2008.08.22~2008.08.24, 第19回霧島神経薬理フォーラム, 主催.
学術論文等の審査
年度 外国語雑誌査読論文数 日本語雑誌査読論文数 国際会議録査読論文数 国内会議録査読論文数 合計
2017年度    
2016年度    
2015年度    
2014年度    
2013年度      
2012年度    
2011年度    
2010年度    
2009年度      
2008年度      
2006年度      
2005年度      
2004年度    
その他の研究活動
海外渡航状況, 海外での教育研究歴
Tentrem Hotel, Indonesia, 2017.07~2017.07.
Columbia University, UnitedStatesofAmerica, 2015.08~2015.08.
The Chinese University of Hong Kong, Hong Kong , 2016.05~2016.05.
Sejong University, Japan, 2016.07~2016.07.
COEX, Korea, 2016.07~2016.07.
Columbia大学, UnitedStatesofAmerica, 2015.08~2015.08.
アンバサダーホテル, Thailand, 2015.06~2015.06.
Kuala Terengganu, Malaysia, 2014.10~2014.11.
Hai Phong Convention Center, Vietnam, 2013.09~2013.09.
Hong Kong Convention and Exibition Centre , Hong Kong , 2012.07~2012.07.
University of Michigan, Columbia University, Duquesne University, UnitedStatesofAmerica, 2012.02~2012.02.
Department of Psychology, Columbia University, UnitedStatesofAmerica, 2007.11~2007.11.
Department of Psychology, Columbia University, UnitedStatesofAmerica, 2005.11~2005.11.
Department of Psychology, Columbia University, UnitedStatesofAmerica, 2008.11~2008.11.
Columbia University, UnitedStatesofAmerica, 2003.06~2003.11.
外国人研究者等の受入れ状況
2014.11~2014.11, 2週間未満, UnitedStatesofAmerica, 学内資金.
2010.04~2010.07, 1ヶ月以上, Uppsala University, Sweden, 学内資金.
2007.10~2007.10, 2週間未満, 広州中医薬大学, China, 私費.
2009.06~2009.06, 2週間未満, Department of Psychology, Columbia University, Japan, 学内資金.
受賞
優秀発表賞, 第26回霧島神経薬理フォーラム, 2015.08.
BIファーマシストアワード, 一般社団法人福岡市薬剤師会、九州大学大学院薬学研究院・臨床育薬学分野, 2014.03.
海外派遣補助金, (財)薬学奨励財団, 2001.06.
研究資金
科学研究費補助金の採択状況(文部科学省、日本学術振興会)
2016年度~2018年度, 基盤研究(C), 分担, 節薬バッグ運動.
2016年度~2018年度, 基盤研究(C), 分担, 節薬バッグ運動.
1999年度~2001年度, 基盤研究(C), 代表, 糖尿病における体内時計同調機能異常に関する研究.
1997年度~1998年度, 基盤研究(C), 代表, 糖尿病モデルラットのリズム異常に関する研究.
1996年度~1997年度, 基盤研究(B), 分担, 諸脳部位における長期増強現象の解明と抗痴呆薬の新しい作用評価系の確立.
共同研究、受託研究(競争的資金を除く)の受入状況
2014.04~2016.03, 分担, 純度Japan Waxの製造法および長期安 定化技術に関する研究.
寄附金の受入状況
2017年度, 佐々木食品株式会社, 奨学寄附金.
2017年度, 公益社団法人大分市薬剤師会, 奨学寄附金.
2017年度, 一般社団法人福岡市薬剤師会, 奨学寄附金.
2016年度, 佐々木食品工業, 奨学寄附金.
2015年度, 佐々木食品工業株式会社, 奨学寄附金.
2015年度, 一般社団法人福岡市薬剤師会, 奨学寄附金.
2014年度, 佐々木食品株式会社, 奨学寄付金.
2014年度, 粕屋地区薬剤師会, 奨学寄付金.
2014年度, 宗像地区薬剤師会, 奨学寄付金.
2014年度, 糸島地区薬剤師会, 奨学寄付金.
2014年度, 筑紫地区薬剤師会, 奨学寄付金.
2014年度, 福岡市薬剤師会, 奨学寄付金.
2013年度, 奨学寄付金.
2012年度, 福岡市薬剤師会, 奨学寄付金.
2006年度, 佐々木食品株式会社, 奨学寄付金.
2004年度, (株)笙嘉, 奨学寄付金.
2003年度, (株)笙嘉, 奨学寄付金.

九大関連コンテンツ

pure2017年10月2日から、「九州大学研究者情報」を補完するデータベースとして、Elsevier社の「Pure」による研究業績の公開を開始しました。
 
 
九州大学知的財産本部「九州大学Seeds集」